Insider Transactions in Q1 2022 at Sensei Biotherapeutics, Inc. (SNSE)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2022
|
William R Ringo |
BUY
Grant, award, or other acquisition
|
Direct |
18,933
+42.28%
|
-
|
|
Mar 02
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
1,203
+0.02%
|
$3,609
$3.2 P/Share
|
|
Mar 02
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
1,203
+0.02%
|
$3,609
$3.2 P/Share
|
|
Mar 01
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,458
+0.05%
|
$7,374
$3.6 P/Share
|
|
Mar 01
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,458
+0.05%
|
$7,374
$3.6 P/Share
|
|
Feb 28
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
42
+0.0%
|
$126
$3.6 P/Share
|
|
Feb 28
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
42
+0.0%
|
$126
$3.6 P/Share
|
|
Feb 25
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,500
+0.05%
|
$7,500
$3.65 P/Share
|
|
Feb 25
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,500
+0.05%
|
$7,500
$3.65 P/Share
|
|
Feb 24
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
15,000
+0.29%
|
$45,000
$3.63 P/Share
|
|
Feb 24
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
15,000
+0.29%
|
$45,000
$3.63 P/Share
|
|
Feb 23
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,500
+0.05%
|
$7,500
$3.8 P/Share
|
|
Feb 23
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,500
+0.05%
|
$7,500
$3.8 P/Share
|
|
Feb 18
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
15,000
+0.29%
|
$45,000
$3.97 P/Share
|
|
Feb 18
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
15,000
+0.29%
|
$45,000
$3.97 P/Share
|
|
Feb 17
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
4,949
+0.1%
|
$19,796
$4.17 P/Share
|
|
Feb 17
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
4,949
+0.1%
|
$19,796
$4.17 P/Share
|
|
Feb 16
2022
|
James Peyer |
BUY
Open market or private purchase
|
Direct |
2,551
+0.05%
|
$10,204
$4.25 P/Share
|
|
Feb 16
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,551
+0.05%
|
$10,204
$4.25 P/Share
|
|
Feb 15
2022
|
John Celebi PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
53,900
+49.9%
|
-
|
|
Feb 15
2022
|
Erin Colgan CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+49.2%
|
-
|
|
Feb 15
2022
|
Robert Hamilton Pierce Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+50.0%
|
-
|
|
Feb 14
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.19%
|
$40,000
$4.18 P/Share
|
|
Feb 14
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
10,000
+0.19%
|
$40,000
$4.18 P/Share
|
|
Feb 11
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
12,500
+0.24%
|
$50,000
$4.4 P/Share
|
|
Feb 11
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
12,500
+0.24%
|
$50,000
$4.4 P/Share
|
|
Feb 10
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
5,000
+0.1%
|
$20,000
$4.58 P/Share
|
|
Feb 10
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.1%
|
$20,000
$4.58 P/Share
|
|
Feb 08
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.19%
|
$40,000
$4.33 P/Share
|
|
Feb 08
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
10,000
+0.19%
|
$40,000
$4.33 P/Share
|
|
Feb 04
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,500
+0.05%
|
$10,000
$4.45 P/Share
|
|
Feb 04
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,500
+0.05%
|
$10,000
$4.45 P/Share
|
|
Feb 03
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
17,500
+0.34%
|
$70,000
$4.65 P/Share
|
|
Feb 03
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
17,500
+0.34%
|
$70,000
$4.65 P/Share
|
|
Jan 28
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
8,900
+0.17%
|
$35,600
$4.22 P/Share
|
|
Jan 28
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
8,900
+0.17%
|
$35,600
$4.22 P/Share
|
|
Jan 27
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
6,100
+0.12%
|
$24,400
$4.31 P/Share
|
|
Jan 27
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
6,100
+0.12%
|
$24,400
$4.31 P/Share
|
|
Jan 26
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
29,900
+0.58%
|
$119,600
$4.62 P/Share
|
|
Jan 26
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
29,900
+0.58%
|
$119,600
$4.62 P/Share
|
|
Jan 25
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
20,100
+0.39%
|
$80,400
$4.86 P/Share
|
|
Jan 25
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
20,100
+0.39%
|
$80,400
$4.86 P/Share
|
|
Jan 24
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
22,707
+0.45%
|
$90,828
$4.69 P/Share
|
|
Jan 24
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
22,707
+0.45%
|
$90,828
$4.69 P/Share
|
|
Jan 21
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
24,703
+0.49%
|
$98,812
$4.94 P/Share
|
|
Jan 21
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
24,703
+0.49%
|
$98,812
$4.94 P/Share
|
|
Jan 20
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
20,000
+0.4%
|
$100,000
$5.17 P/Share
|
|
Jan 20
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.4%
|
$100,000
$5.17 P/Share
|
|
Jan 19
2022
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
10,244
+0.2%
|
$40,976
$4.97 P/Share
|
|
Jan 19
2022
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
10,244
+0.2%
|
$40,976
$4.97 P/Share
|